Archives des news - Medicen


  • Digi-B-Cube Label-Medicen

    DIGI-B-CUBE project is launching an open call for funding on 22nd April 2020, to support projects focusing on integrating digital innovations and disruptive technologies across the Medical Diagnostics and related value chains. Small and Medium Enterprises (including new start-ups) operating in the health, medicine, biotech, biopharma, IT or related sectors (robotics, automation, electronics, nanotech etc.) can apply for equity-free funding up to €60,000 through the DIGI-B-CUBE voucher scheme.

    DIGI-B-CUBE Vouchers 

    • Prototyping Vouchers : up to €20.000 per SME and €60.000 per project 
      1st Deadline: 29th July 2020
      2nd Deadline: 3rd February 2021
      Receive funding to prototype or conceptualise a solution for a digitalisation challenge in the Medical Diagnostics and related value chains. Consortia consisting of minimum two SMEs and maximum three organisations from at least two different sectors will be funded.

    • Customised Solution Innovation Vouchers: up to €50.000 per SME and €150.000 per project
      1st Deadline: 29th July 2020
      2nd Deadline: 3rd February 2021
      Receive funding to jointly develop a novel product/service based on an existing proven concept that addresses a digitalisation challenge in the Medical Diagnostics and related value chains. Consortia consisting of minimum two SMEs from at least two different sectors will be funded.

    • Travel Voucher: up to €2.000 per voucher and €6.000 per SME 
      Available now Get reimbursed for your travel costs (transportation, accommodation and event fees) incurred for attending DIGI-B-CUBE events.
      Applications must be submitted prior to the event.
      Find the official announcement here: DIGI-B-CUBE Travel Vouchers Announcement (pdf)
      Find the FAQs here: DIGI-B-CUBE Travel Vouchers FAQ (pdf)


  • Medicen Paris Region appoints Jessica Leygues as CEO Label-Medicen

    With many years of valuable experience, Jessica Leygues will launch concrete reindustrialization initiatives to accelerate growth in the French healthcare industry and boost national sovereignty in order to recover from the COVID-19 pandemic

    Paris, April 20, 2020 – Medicen Paris Region, Europe’s leading health cluster, today announces the appointment of Jessica Leygues as CEO with approval from the board of directors. She starts her new role at a particularly complex time due to the COVID-19 crisis, which calls for the cluster’s priorities to be reassessed. She will be responsible for implementing crisis exit strategies for cluster members and the health sector.

    “We are proud to welcome Jessica to Medicen. Her expertise and character match the challenges that lie before us,” said Christian Lajoux, President of Medicen Paris Region. “The transition management team has been in place for several weeks and has dealt with the damage caused by the pandemic with great professionalism. In the context of other healthcare clusters, we have immediately responded to the demands for cooperation from the Île-de-France region, the Directorate General for Enterprise (DGE), government agencies and healthcare facilities.”

    Medicen’s solid foundation alongside the expertise of its employees on the ecosystem have helped to rapidly set up a highly praised COVID-19 toolkit. For a number of weeks, the cluster has been focusing on medtech companies, particularly those developing diagnostic and digital medical devices.

    “I am delighted to join Medicen, at a key point in time when the cluster’s priorities need to be reassessed, as required after the COVID-19 pandemic. Close dialogue must be encouraged with teams, governance and all stakeholders within the Île-de-France region,” said Leygues. “We will need to initiate concrete reindustrialization projects to aid growth and rebuild national sovereignty for the healthcare industry. In particular, we will support micro businesses and SMEs through a groundbreaking, innovative dynamic for healthcare priorities and as part of an open approach to European ecosystems.”

    Medicen is aware of the special role of a healthcare cluster as well as its network within the management and exit strategy of the COVID-19 crisis with the need to implement economic initiatives based on research and clinical development. This will be achieved by its strong commitment toward cooperation and a cross-sectoral approach, emphasizing that its identity will always be expressed in terms of industrialization and national sovereignty through a European and international approach.

    Leygues, a graduate in engineering from the Paris Institute of Technology for Life, Food and Environmental Sciences (AgroParisTech), started her career at the Alcimed consulting firm. There, she spent eight years developing new healthcare markets (biotech/medtech) for entrepreneurs, start-ups, SMEs and large corporations as well as for the public and parapublic innovation sector, including the French Ministry of Research, research institutes, competitiveness clusters and knowledge transfer centers. Strongly committed to optimization initiatives for healthcare systems, Leygues then joined the pharmaceutical company Celgene, where she was responsible for an innovative partnership hub aimed at developing the healthcare value model. Leygues also set up and launched the Celgene ‘Innovation Lab’ to stimulate creativity, serendipity and collaborative work.




  • Bio-Europe Spring Label-Medicen

    Medicen will shortly be hosting the 2020 edition of BIO-Europe Spring following the great success of the 2015 conference in our region. 

    The international partnering conference, which will take place from March 23rd to 25th, is organised together with Choose Paris Region and the Paris Region Council. Our booth will showcase innovative biotechs from the Paris region and other dynamic French territories. It will also highlight advances in personalised medicine and biopharma 3.0.